1. Home
  2. SNGX vs SINT Comparison

SNGX vs SINT Comparison

Compare SNGX & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.33

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.39

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
SINT
Founded
1987
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
11.1M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
SNGX
SINT
Price
$0.33
$2.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$11.00
AVG Volume (30 Days)
1.3M
35.6K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
59.45
EPS
N/A
N/A
Revenue
$119,371.00
$1,018,000.00
Revenue This Year
N/A
$30.26
Revenue Next Year
N/A
$413.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.99
52 Week High
$6.23
$6.78

Technical Indicators

Market Signals
Indicator
SNGX
SINT
Relative Strength Index (RSI) 24.56 44.26
Support Level N/A $2.30
Resistance Level $1.48 $2.64
Average True Range (ATR) 0.05 0.20
MACD -0.03 0.01
Stochastic Oscillator 4.90 53.44

Price Performance

Historical Comparison
SNGX
SINT

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

Share on Social Networks: